New and emerging HDAC inhibitors for cancer treatmentAlison C. West, Ricky W. Johnstone|Journal of Clinical Investigation|2014Cited by 1.4k
The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shockAlison C. West, Jake Shortt|Oncogenesis|2016Cited by 32